Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

State of the Journal: 2011

State of the Journal: 2011 EDITORIAL State of the Journal: 2011 James R. Jett, MD e are observing our 5-year anniversary, and there are many reasons to celebrate. Our Wmanuscript submissions have more than tripled since 2006. In 2009, we received 800 submissions, and subsequently in 2010, the total electronic submissions numbered more than 1000, and of these, 600-plus were original articles. The average time to first decision is 21 days for all submissions and 28 days for original articles. Because of the marked increase in original submissions, the acceptance rate of this year was 35% having decreased significantly from previous years. This reflects the improved quality of published articles in Journal of Thoracic Oncology. The result of higher quality articles published, is a yearly increase in the impact factor for the Journal. The first impact factor registered for 2008 was 3.5. For 2009, it was 4.55, and the 2010 impact factor will be received in June of this year. Although impact factors are not the sole measure of a journal’s success, authors often take this into consideration when choosing a journal for manuscript submission. In the past year, there has been continuous improvement in the Journal of Thoracic Oncology Web site. The homepage features a “Publish ahead of print” link for original and review articles. We have started a “Collections” feature where all of the International Association for the Study of Lung Cancer (IASLC) staging committee articles are listed together and are available to anyone, member or not. Other collections include “Biostatistics for Clinicians” and “Images of the Month.” Plans are in the works to expand these “Collections” for our Journal of Thoracic Oncology readers. Also found on the homepage is a “Quick Poll” feature, and our intentions are to include unknown images to test your clinical knowledge. The Web site also includes a section called “Most Popular,” which lists the most viewed, most emailed, and highest impact articles that have appeared in Journal of Thoracic Oncology. Of note is that the top three highest impact articles were all products of the IASLC Staging Committee. Along this line, stay tuned for the new pathology classification of adenocarcinoma article, which will appear in February or March. This too is a product of a joint committee of IASLC, American Thoracic Society, and European Respiratory Society and chaired by Dr. William Travis. This promises to a landmark publication. The Journal of Thoracic Oncology Web site has experienced an increase in traffic. In 2010, the site had approximately 19,000 visits per month, with an average of 1770 pages viewed per day. Sixty percent of the visitors were from outside the United States, and this clearly reflects the international nature of our organization and the Journal of Thoracic Oncology. Although the Journal of Thoracic Oncology is making consistent progress, we certainly do not plan to rest. It is our goal to increase readership, expand features on the Web site, and enhance the overall quality and significance of the Journal. To achieve this goal, we are dependent on our readers, manuscript reviewers, and authors. To our manuscript reviewers, in particular for their dedicated hard work, we extend our sincere thanks. The complete list of Journal of Thoracic Oncology reviewers for 2010 will be published in the March issue. I wish to extend personal thanks to our associate editors and the superb editorial team for the their outstanding work. The Journal of Thoracic Oncology Associate Editors, listed in each issue of Journal of Thoracic Oncology, are leaders in their respective fields and contribute their precious time to the success of the Journal. For this, I am deeply appreciative. How do we make Journal of Thoracic Oncology better? Because this is your Journal, please do not hesitate to offer ideas, suggestions, criticisms, critiques, etc. to improve the quality of the Journal and the Web site. I value your input. Department of Medicine, National Jewish Health, Denver, Colorado. Disclosure: James R. Jett, MD, serves as Editor-in-Chief of the Journal of Thoracic Oncology. There are no other disclosures related to this article. Address for correspondence: James R. Jett, MD, National Jewish Health, Denver, CO. E-mail: JettJ@NJHealth.org Copyright © 2010 by the International Association for the Study of Lung Cancer ISSN: 1556-0864/11/0601-0001 Journal of Thoracic Oncology  Volume 6, Number 1, January 2011 1 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

State of the Journal: 2011

Jett, James R.
Journal of Thoracic Oncology , Volume 6 (1) – Jan 1, 2011
Download PDF
1 page

Loading next page...
 
/lp/wolters-kluwer-health/state-of-the-journal-colon-2011-B3oonU4PAc

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3182068e8b
pmid
21178711
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL State of the Journal: 2011 James R. Jett, MD e are observing our 5-year anniversary, and there are many reasons to celebrate. Our Wmanuscript submissions have more than tripled since 2006. In 2009, we received 800 submissions, and subsequently in 2010, the total electronic submissions numbered more than 1000, and of these, 600-plus were original articles. The average time to first decision is 21 days for all submissions and 28 days for original articles. Because of the marked increase in original submissions, the acceptance rate of this year was 35% having decreased significantly from previous years. This reflects the improved quality of published articles in Journal of Thoracic Oncology. The result of higher quality articles published, is a yearly increase in the impact factor for the Journal. The first impact factor registered for 2008 was 3.5. For 2009, it was 4.55, and the 2010 impact factor will be received in June of this year. Although impact factors are not the sole measure of a journal’s success, authors often take this into consideration when choosing a journal for manuscript submission. In the past year, there has been continuous improvement in the Journal of Thoracic Oncology Web site. The homepage features a “Publish ahead of print” link for original and review articles. We have started a “Collections” feature where all of the International Association for the Study of Lung Cancer (IASLC) staging committee articles are listed together and are available to anyone, member or not. Other collections include “Biostatistics for Clinicians” and “Images of the Month.” Plans are in the works to expand these “Collections” for our Journal of Thoracic Oncology readers. Also found on the homepage is a “Quick Poll” feature, and our intentions are to include unknown images to test your clinical knowledge. The Web site also includes a section called “Most Popular,” which lists the most viewed, most emailed, and highest impact articles that have appeared in Journal of Thoracic Oncology. Of note is that the top three highest impact articles were all products of the IASLC Staging Committee. Along this line, stay tuned for the new pathology classification of adenocarcinoma article, which will appear in February or March. This too is a product of a joint committee of IASLC, American Thoracic Society, and European Respiratory Society and chaired by Dr. William Travis. This promises to a landmark publication. The Journal of Thoracic Oncology Web site has experienced an increase in traffic. In 2010, the site had approximately 19,000 visits per month, with an average of 1770 pages viewed per day. Sixty percent of the visitors were from outside the United States, and this clearly reflects the international nature of our organization and the Journal of Thoracic Oncology. Although the Journal of Thoracic Oncology is making consistent progress, we certainly do not plan to rest. It is our goal to increase readership, expand features on the Web site, and enhance the overall quality and significance of the Journal. To achieve this goal, we are dependent on our readers, manuscript reviewers, and authors. To our manuscript reviewers, in particular for their dedicated hard work, we extend our sincere thanks. The complete list of Journal of Thoracic Oncology reviewers for 2010 will be published in the March issue. I wish to extend personal thanks to our associate editors and the superb editorial team for the their outstanding work. The Journal of Thoracic Oncology Associate Editors, listed in each issue of Journal of Thoracic Oncology, are leaders in their respective fields and contribute their precious time to the success of the Journal. For this, I am deeply appreciative. How do we make Journal of Thoracic Oncology better? Because this is your Journal, please do not hesitate to offer ideas, suggestions, criticisms, critiques, etc. to improve the quality of the Journal and the Web site. I value your input. Department of Medicine, National Jewish Health, Denver, Colorado. Disclosure: James R. Jett, MD, serves as Editor-in-Chief of the Journal of Thoracic Oncology. There are no other disclosures related to this article. Address for correspondence: James R. Jett, MD, National Jewish Health, Denver, CO. E-mail: JettJ@NJHealth.org Copyright © 2010 by the International Association for the Study of Lung Cancer ISSN: 1556-0864/11/0601-0001 Journal of Thoracic Oncology  Volume 6, Number 1, January 2011 1

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Jan 1, 2011

There are no references for this article.